This secondary analysis of a randomized clinical trial examines the association of modern chemoradiotherapy with survival among patients with stage I to II small cell lung cancer compared with that among patients with stage III small cell lung cancer.
https://ift.tt/2BeLCg1
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου